Start free

Standard Biotools Inc. (LAB) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 5, 2026.

Filings shown
16
Open-market buys
1
Open-market sells
0
Buys, 10b5-1 box not checked
1 of 1

Counts cover the 16 most recent Form 4 filings Tradune holds for LAB (filed May 22 – Nov 5, 2026); the score below covers only the trailing 90 days (1 buy, 0 sells). SEC EDGAR Form 4 filings for LAB last checked Nov 21, 2026, 09:00 UTC; the latest LAB filing Tradune holds was filed Nov 5, 2026. This is not guaranteed to be the complete record — see LAB's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 4 filings Tradune holds for LAB filed Aug 24 – Nov 5, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Thomas D. CareyDirector 1 0 75,000 — +$46,898

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

56/ 100

Net insider purchases
1 distinct buyer1 buy · 0 sell txofficer buying

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at LAB

Insiders reported 1 open-market purchase of LAB between May 22, 2026 and Nov 5, 2026, across 1 distinct buyer. The most recent purchase was reported by Thomas D. Carey (Director) on Nov 5, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Thomas D. Carey Director · filed Nov 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 75,000 $0.63 419,456 +22% Nov 5, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Sean Mackay SVP & Chief Business Officer · filed Aug 24, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 25,729 $0.67 1,480,823 −1.7% Aug 20, 2026
Hanjoon Alex Kim Chief Financial Officer · filed Aug 24, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 28,195 $0.67 2,534,859 −1.1% Aug 20, 2026
Michael Egholm President & CEO · filed Aug 24, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 97,627 $0.67 6,137,704 −1.6% Aug 20, 2026
Michael Egholm President & CEO · filed Aug 4, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 362,625 $0.87 6,235,331 −5.5% Aug 3, 2026
Hanjoon Alex Kim Chief Financial Officer · filed Jul 27, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 202,476 $0.90 2,563,054 −7.3% Jul 23, 2026
Sean Mackay SVP & Chief Business Officer · filed Jun 23, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 500,000 — 1,506,552 +50% Jun 20, 2026
Thomas D. Carey Director · filed Jun 23, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 99,116 — 344,456 +40% Jun 18, 2026
Grant / award Stock Option (Right to buy) 263,884 — — — Jun 18, 2026
Frank Witney Director · filed Jun 23, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 99,116 — 309,978 +47% Jun 18, 2026
Grant / award Stock Option (Right to buy) 175,923 — — — Jun 18, 2026
Eli Casdin Director, 10% owner · filed Jun 23, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 99,116 — 3,053,169 +3.4% Jun 18, 2026
Grant / award Stock Option (Right to buy) 175,923 — — — Jun 18, 2026
Troy Cox Director · filed Jun 23, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 99,116 — 475,702 +26% Jun 18, 2026
Grant / award Stock Option (Right to buy) 175,923 — — — Jun 18, 2026
Fenel M. Eloi Director · filed Jun 23, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to buy) 175,923 — — — Jun 18, 2026
Grant / award 99,116 — 335,299 +42% Jun 18, 2026
Kathy L. Hibbs Director · filed Jun 23, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 99,116 — 236,836 +72% Jun 18, 2026
Grant / award Stock Option (Right to buy) 175,923 — — — Jun 18, 2026
Hanjoon Alex Kim Chief Financial Officer · filed May 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 18,871 $1.00 2,760,530 −0.7% May 20, 2026
Sean Mackay SVP & Chief Business Officer · filed May 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 25,729 $1.00 1,006,552 −2.5% May 20, 2026
Michael Egholm President & CEO · filed May 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 97,626 $1.00 6,597,956 −1.5% May 20, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to LAB's (Nov 5, 2026).

Frequently asked about LAB insider activity

How many insiders bought LAB stock in these Form 4 filings?

1 distinct insider at Standard Biotools Inc. reported 1 open-market purchase (Form 4 code P) of LAB shares between May 22, 2026 and Nov 5, 2026, the most recent filed by Thomas D. Carey (Director) on Nov 5, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for LAB?

The most recent Form 4 on this page was filed by Thomas D. Carey (Director) on Nov 5, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market LAB insider purchase shown?

The largest open-market purchase among the filings shown was 75,000 LAB shares at $0.63 (about $46,898) by Thomas D. Carey (Director) on Nov 5, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent LAB insider purchases have the Form 4 10b5-1 box checked?

No. The one LAB open-market purchase shown was reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Thomas D. Carey (Director) on Nov 5, 2026, 75,000 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for LAB — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.